InfuSystem Holdings, Inc
InfuSystem Holdings, Inc. provides outpatient infusion and related durable medical equipment services through two platforms: Patient Services and Device Solutions. The company supports oncology, wound care, pain management, hospitals, ambulatory surgery centers, and other alternate-site providers with pumps, disposables, logistics, billing, and biomedical repair services.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueClinic-to-home infusion support, including pump management, billing, logistics, and related patient care services.
Sale, rental, maintenance, repair, and biomedical certification of infusion pumps and other DME.
Treatment-related disposable kits, supply items, and ancillary products used with infusion and wound care therapies.
Joint-venture and distribution offerings such as advanced wound care and oral mucositis products.
Customers
The company sells primarily to healthcare providers that manage outpatient infusion and related therapies, especially oncology practices and hospital outpatient chemotherapy clinics. It also serves ambulatory surgery centers, wound care providers, home infusion/home care operators, skilled nursing facilities, pain centers, and other alternate-site care settings. Demand is driven by the need for reliable pump access, reimbursement support, and service coverage that smaller local providers often cannot match.
Buy ambulatory infusion pumps, disposable kits, and support services for cancer treatment delivery.
Use pumps and supply kits for outpatient infusion workflows and treatment continuity.
Purchase rental, repair, logistics, and billing support to outsource DME handling.
Buy pumps, maintenance, and biomedical services to support clinic-to-home care.
Use NPWT products and ambulatory pumps for wound healing and post-surgical pain treatment.
Strategy
The company is focused on expanding its Patient Services platform by leveraging payer contracts, logistics, and clinical/biomedical capabilities to deepen its role in clinic-to-home care. It is also using Device Solutions, partnerships, and IT tools to broaden the offering, add adjacent products, and improve customer retention. Capital allocation remains centered on organic growth, acquisitions, and selective share repurchases while maintaining liquidity for equipment purchases and working capital.
Broader reimbursement access improves collections and reduces concessions.
Existing provider relationships can support incremental equipment and service sales.
Partnerships diversify revenue beyond infusion pumps and deepen clinical relevance.
Technology and service quality support retention and operational efficiency.
Geography
InfuSystem operates from seven locations in the United States and Canada, with headquarters in Rochester Hills, Michigan. Its service model depends on local field support and repair centers in Michigan, Kansas, California, Massachusetts, Texas, and Ontario, which helps it provide same-day or next-day delivery and service coverage. The business is concentrated in North America, so reimbursement, labor, and supplier conditions in the U.S. and Canada are the main geographic drivers.
Risks
The business is highly exposed to third-party reimbursement, so changes in payer rates, collections timing, or concessions can directly affect revenue and margins. It also depends on a concentrated supplier base for key pumps and on uninterrupted IT and service operations, making supply-chain and cybersecurity disruptions meaningful operational risks. Because the company serves regulated healthcare workflows across North America, compliance, reimbursement, and execution risk remain central.
- Reimbursement pressure and payer mix changesImpact: HighLikelihood: Medium
Revenue depends heavily on third-party insurers and government payers.
Exposure - Supplier concentration for ambulatory pumpsImpact: HighLikelihood: Medium
A large share of pumps is sourced from a limited number of manufacturers.
Exposure - Cybersecurity and IT disruptionImpact: HighLikelihood: Medium
Operations rely on third-party systems and sensitive patient information.
Exposure - Operational execution across distributed service locationsImpact: Medium
Same-day delivery and repair depend on field technicians and local centers.
Exposure - Foreign exchange and cross-border exposureImpact: Low
The company has Canadian operations and foreign-currency transactions.
Exposure: Translation and transaction effects on costs and revenue
Accounting
Judgemental itemsBilled revenue, payer allowances, and collections can differ materially.
Impact: Affects net revenue, accounts receivable, and margin comparability
The company operates from multiple owned/leased service locations.
Impact: Affects operating assets, liabilities, and fixed-cost visibility
Acquisitions such as FilAMed and OB Healthcare add acquired assets.
Impact: Potential impairment charges if acquired businesses underperform
The business holds pumps for rental, sale, repair, and refurbishment.
Impact: Affects cost of sales, depreciation, and asset carrying values
Treatment volume, rental buyouts, and shipment timing can move results.
Impact: Can distort sequential comparisons and working capital needs
Similar listed companies
Publicly listed companies with a comparable business focus.
Insulet Corporation
PODD · Surgical & Medical Instruments & Apparatus
Insulet Corporation develops, manufactures, and sells the Omnipod platform, a tubeless continuous insulin delivery system for people with insulin-dependent diabetes.
ICU Medical, Inc
ICUI · Surgical & Medical Instruments & Apparatus
ICU Medical develops, manufactures, and sells medical devices and software used in infusion therapy, vascular access, and critical care settings.
Tactile Systems Technology, Inc
TCMD · Surgical & Medical Instruments & Apparatus
Tactile Systems Technology is a U.S.-based medical technology company that develops and sells home-based devices for chronic disease management.
TriSalus Life Sciences, Inc.
TLSI · Surgical & Medical Instruments & Apparatus
TriSalus Life Sciences is a U.S.-based medical device company focused on catheter-based infusion systems used in interventional oncology procedures.
KORU Medical Systems, Inc.
KRMD · Surgical & Medical Instruments & Apparatus
KORU Medical Systems develops, manufactures, and commercializes portable large-volume subcutaneous infusion solutions used to deliver drugs under the FREEDOM Infusion System brand.
iRadimed Corporation
IRMD · Surgical & Medical Instruments & Apparatus
IRADIMED Corp designs and sells MRI-compatible medical devices used inside scanner rooms, centered on infusion pumps, patient vital signs monitoring systems, and related disposables and service.
Last updated: 24/09/2026